Julien Schopp

TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects

A. Eschalier, M. Meleine, J. Busserolles, 2020, British journal of pharmacology.

The TREK-1 potassium channel is involved in both the analgesic and anti-proliferative effects of riluzole in bone cancer pain.

M. Meleine, J. Busserolles, Y. Aissouni, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.